Structural Insights Into Oligomerization and Mitochondrial Remodeling of Dynamin 1-Like Protein

Structural Insights Into Oligomerization and Mitochondrial Remodeling of Dynamin 1-Like Protein

Structural insights into oligomerization and mitochondrial remodeling of dynamin 1-like protein Dissertation zur Erlangung des akademischen Grades des Doktors der Naturwissenschaften (Dr. rer. nat.) eingereicht im Fachbereich Biologie, Chemie, Pharmazie der Freien Universität Berlin vorgelegt von Dipl.-Ing. Chris Fröhlich aus der Lutherstadt Eisleben Berlin 2013 ii Die vorliegende Arbeit wurde im Zeitraum April 2009 bis März 2013 am Max-Delbrück-Centrum für Molekulare Medizin Berlin-Buch unter Anleitung von PROF. DR. OLIVER DAUMKE angefertigt. 1. Gutachter: Prof. Dr. Udo Heinemann 2. Gutachter: Prof. Dr. Oliver Daumke Tag der Disputation: 29.07.2013 iii … to boldly go where no man has gone before. iv Contents ___________________________________________________________________________ Contents Contents ................................................................................................................................................... v List of Figures ........................................................................................................................................... ix List of Tables ............................................................................................................................................ xi 1. Introduction ..................................................................................................................................... 1 1.1. Mitochondria ........................................................................................................................... 1 1.1.1. The mitochondrial compartment .................................................................................... 2 1.1.2. The mitochondrial network ............................................................................................. 5 1.1.3. Mitochondria associated diseases .................................................................................. 6 1.2. G proteins ................................................................................................................................ 8 1.3. The dynamin superfamily of G proteins ................................................................................ 10 1.3.1. Dynamin ........................................................................................................................ 12 1.3.1.1. Dynamins are key players in clathrin-mediated endocytosis ................................ 12 1.3.1.2. The G domain and the bundle signaling element ................................................. 14 1.3.1.3. G domain dimerization is crucial for dynamin function ........................................ 15 1.3.1.4. Dynamin's PH domain mediates lipid binding ....................................................... 17 1.3.1.5. The stalk is the central assembly hub for dynamin oligomerization ..................... 17 1.3.1.6. Regulatory functions of the stalk .......................................................................... 20 1.3.1.7. Functional models of dynamin's mechano-chemical action ................................. 20 1.3.2. Myxovirus resistance (Mx) proteins .............................................................................. 22 1.3.2.1. Mx proteins mediate antiviral host response ....................................................... 22 1.3.2.2. Different functions - similar structures: MxA and dynamin 1 ............................... 23 1.3.2.3. The MxA stalk mediates oligomerization and regulatory function ....................... 24 1.3.2.4. The MxA stalk mediates assembly in rings rather than helices ............................ 25 1.3.3. Bacterial dynamin-like proteins (BDLPs) ....................................................................... 26 1.3.4. Guanylate-binding proteins (GBPs) ............................................................................... 28 1.3.5. Eps15 homology-domain containing proteins (EHDs) ................................................... 29 1.3.6. Mitochondrial fusion dynamins..................................................................................... 31 1.3.6.1. Mitochondrial outer membrane fusion dynamins ................................................ 31 1.3.6.2. Mitochondrial inner membrane fusion dynamins ................................................ 32 1.3.7. The mitochondrial fission dynamin 1-like protein (DNM1L) ......................................... 32 1.3.7.1. DNM1L is a key player in mitochondrial fission .................................................... 32 v Contents ___________________________________________________________________________ 1.3.7.2. Recruitment of DNM1L to mitochondria scission sites involves certain adaptor proteins and the endoplasmic reticulum (ER) ........................................................................... 33 1.3.7.3. Two-start versus one-start helix ............................................................................ 34 1.4. Scope of this work ................................................................................................................. 36 2. Materials and Methods ................................................................................................................. 38 2.1. Materials ................................................................................................................................ 38 2.1.1. Chemicals ....................................................................................................................... 38 2.1.2. Antibodies...................................................................................................................... 38 2.1.3. Enzymes ......................................................................................................................... 38 2.1.4. Kits ................................................................................................................................. 39 2.1.5. Microorganisms and cell lines ....................................................................................... 39 2.1.6. Vectors ........................................................................................................................... 40 2.1.7. cDNA clone .................................................................................................................... 40 2.1.8. Primers .......................................................................................................................... 40 2.1.8.1. Cloning Primers ..................................................................................................... 40 2.1.8.2. Quick change mutagenesis primers ...................................................................... 40 2.1.9. Media and antibiotics .................................................................................................... 42 2.1.10. Buffers ........................................................................................................................... 42 2.2. Molecular biology methods................................................................................................... 43 2.2.1. Polymerase chain reaction ............................................................................................ 43 2.2.2. DNA digestion ................................................................................................................ 43 2.2.3. Agarose gel electrophoresis .......................................................................................... 43 2.2.4. DNA purification ............................................................................................................ 43 2.2.5. Ligation .......................................................................................................................... 44 2.2.6. Preparation of chemically competent E. coli ................................................................. 44 2.2.7. Transformation of chemically competent E. coli ........................................................... 44 2.2.8. Isolation of plasmid DNA ............................................................................................... 44 2.2.9. DNA sequencing ............................................................................................................ 44 2.2.10. Site specific mutagenesis............................................................................................... 44 2.2.11. Sequence alignments .................................................................................................... 45 2.2.12. Bacterial storage ............................................................................................................ 45 2.2.13. Construct design ............................................................................................................ 45 2.3. Biochemical methods ............................................................................................................ 45 2.3.1. SDS PAGE ....................................................................................................................... 45 2.3.2. Protein over-expression test in E. coli ........................................................................... 45 vi Contents ___________________________________________________________________________ 2.3.3. Protein solubility test .................................................................................................... 46 2.3.4. Large scale protein over-expression in E. coli ..............................................................

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    142 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us